Luís Colomo - Concepedia

Author

Luís Colomo

Also Known As

Antonio Martnez-Pozo, L Colomo, L. Colomo, L. Jiménez Colomo, LLUÍS COLOMO, Lluis Colomo, Lluís Colomo, Lluís Colomo‐Saperas, Luis Colomo, Luís Colomo

121

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

Universitat de Barcelona Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Hospital Clínic de Barcelona Hospital Del Mar Hospital del Mar Research Institute

About

Luís Colomo is an author at Universitat de Barcelona specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	21	1.9K
2	Cell Biology	10	10	928
3	Natural Sciences	1	1	19
4	Biochemistry	1	1	19
5	Cellular Therapies	1	1	198

Luís Colomo

Publications

Citations

H-Index

Page 1

	Year	Citations
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma Rafael Valdés‐Mas, Alba Navarro, Itziar Salaverría, Proceedings of the National Academy of Sciences	2013	515
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma Joaquim Carreras, Armando López‐Guillermo, Bridget C. Fox, Blood	2006	501
Diffuse Large B-cell Lymphomas With Plasmablastic Differentiation Represent a Heterogeneous Group of Disease Entities Luís Colomo, Florence Loong, Susana Rives, The American Journal of Surgical Pathology ImmunologyPlasmablastic LymphomaPathologyBlood CellImmunotherapy	2004	412
Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy Gonzalo Gutiérrez, Teresa M. Cardesa‐Salzmann, Fina Climent, Blood	2011	317
High Numbers of Tumor-Infiltrating Programmed Cell Death 1–Positive Regulatory Lymphocytes Are Associated With Improved Overall Survival in Follicular Lymphoma Joaquim Carreras, Armando López‐Guillermo, Giovanna Roncador, Journal of Clinical Oncology	2009	292
Diffuse Large B-Cell Lymphoma: Clinical and Biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin Armando López‐Guillermo, Luís Colomo, Mónica Jiménez, Journal of Clinical Oncology	2005	284
IG/MYC Rearrangements are the Main Cytogenetic Alteration in Plasmablastic Lymphomas Alexandra Valera, Olga Balagué, Luís Colomo, The American Journal of Surgical Pathology Hematological MalignancyLymphoid NeoplasiaMyc RearrangementsMedicineMixed-phenotype Acute Leukemia	2010	274
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy Alexandra Valera, Armando López‐Guillermo, Teresa M. Cardesa‐Salzmann, Haematologica ImmunologyPathologyMyc AmplificationsImmunotherapyTumor Biology	2013	225
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma Santiago Mercadal, Javier Briones, Blanca Xicoy, Annals of Oncology Lymphoid NeoplasiaCell TherapyTransplantationMarrow TransplantationMedicine	2008	198
Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets Kennosuke Karube, Anna Enjuanes, Iván Dlouhy, Leukemia	2017	178

Page 1